[
  {
    "ts": null,
    "headline": "These 20 worst-performing stocks in the S&P 500 sank 17% or more in March",
    "summary": "These 20 worst-performing stocks in the S&P 500 sank 17% or more in March",
    "url": "https://finnhub.io/api/news?id=5cb18435ede04f6f2735d872fd612ecef3de09629588b04c99183869b77c31a6",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743440520,
      "headline": "These 20 worst-performing stocks in the S&P 500 sank 17% or more in March",
      "id": 133640701,
      "image": "",
      "related": "DXCM",
      "source": "MarketWatch",
      "summary": "These 20 worst-performing stocks in the S&P 500 sank 17% or more in March",
      "url": "https://finnhub.io/api/news?id=5cb18435ede04f6f2735d872fd612ecef3de09629588b04c99183869b77c31a6"
    }
  },
  {
    "ts": null,
    "headline": "DXCM Inks Deal With Nanowear to Boost CGM Application Beyond Diabetes",
    "summary": "DexCom's recent licensing deal with Nanowear is likely to reinforce the broader potential of CGMs in continuous metabolic health monitoring.",
    "url": "https://finnhub.io/api/news?id=e7f3a2fdeb4469d28849be47beed22d90075a78169bb5d09db9dc63c39b3ef88",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743427800,
      "headline": "DXCM Inks Deal With Nanowear to Boost CGM Application Beyond Diabetes",
      "id": 133628095,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "DexCom's recent licensing deal with Nanowear is likely to reinforce the broader potential of CGMs in continuous metabolic health monitoring.",
      "url": "https://finnhub.io/api/news?id=e7f3a2fdeb4469d28849be47beed22d90075a78169bb5d09db9dc63c39b3ef88"
    }
  }
]